共 28 条
[1]
[2]
Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis[J] Yun-Xia Chen;Li-Na Lai;Hui-Ying Zhang;Yang-Hui Bi;Li Meng;Xu-Jiong Li;Xiao-Xia Tian;Li-Min Wang;Yi-Min Fan;Zhong-Fu Zhao;De-Wu Han;Cheng Ji; World Journal of Gastroenterology 2016,
[3]
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease[J] Kouichi Miura;Hirohide Ohnishi; World Journal of Gastroenterology 2014,
[4]
Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects[J] Chen-Shuan Chung;Pi-Feng Chang;Chun-Hsing Liao;Tzong-Hsi Lee;Yun Chen;Yi-Chia Lee;Ming-Shiang Wu;Hsiu-Po Wang;Yen-Hsuan Ni Scandinavian Journal of Gastroenterology 2016,
[5]
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota[J] Jér?me Boursier;Olaf Mueller;Matthieu Barret;Mariana Machado;Lionel Fizanne;Felix Araujo‐Perez;Cynthia D. Guy;Patrick C. Seed;John F. Rawls;Lawrence A. David;Gilles Hunault;Frédéric Oberti;Paul Calès;Anna Mae Diehl Hepatology 2016,
[6]
Bacterial overgrowth and diversification of microbiota in gastric cancer[J] Lili Wang;Jianhua Zhou;Yongning Xin;Changxin Geng;Zibin Tian;Xinjuan Yu;Quanjiang Dong European Journal of Gastroenterology & Hepatology 2016,
[7]
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota[J] Vétizou Marie;Pitt Jonathan M.;Daillère Romain;Lepage Patricia;Waldschmitt Nadine;Flament Caroline;Rusakiewicz Sylvie;Routy Bertrand;Roberti Maria P.;Duong Connie P. M.;Poirier-Colame Vichnou;Roux Antoine;Becharef Sonia;Formenti Silvia;Golden Encouse;Cording Sascha;Eberl Gerard;Schlitzer Andreas;Ginhoux Florent;Mani Sridhar;Yamazaki Takahiro;Jacquelot Nicolas;Enot David P.;Bérard Marion;Nigou Jér?me;Opolon Paule;Eggermon
[8]
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy[J] Sivan Ayelet;Corrales Leticia;Hubert Nathaniel;Williams Jason B.;Aquino-Michaels Keston;Earley Zachary M.;Benyamin Franco W.;Man Lei Yuk;Jabri Bana;Alegre Maria-Luisa;Chang Eugene B.;Gajewski Thomas F. Science 2015,
[9]
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis[J] Zeneng Wang;Adam B. Roberts;Jennifer A. Buffa;Bruce S. Levison;Weifei Zhu;Elin Org;Xiaodong Gu;Ying Huang;Maryam Zamanian-Daryoush;Miranda K. Culley;Anthony J. DiDonato;Xiaoming Fu;Jennie E. Hazen;Daniel Krajcik;Joseph A. DiDonato;Aldons J. Lusis;Stanley L. Hazen Cell 2015,
[10]
The FXR-FGF19 Gut–Liver Axis as a Novel “Hepatostat”[J] Matias A. Avila Gastroenterology 2015,